John M. Evans, CEO at Beam Therapeutics Inc. (BEAM), sold 12,522 shares at $59.11 ($740K) on 2022-03-31, disclosed to the SEC on 2022-04-04.
Open-market sale of $740k BEAM by CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $59.11 | 6,261 | $370K | 50.0% |
| 2 | $59.11 | 6,261 | $370K | 50.0% |
| Total | $59.11 avg | 12,522 | $740K | 100% |
| Filing → |
| BEAM | SELL | 2026-04-01 | $1.1M | — | Filing → |
| BEAM | SELL | 2026-02-02 | $2.8M | — | Filing → |
| BEAM | SELL | 2025-10-03 | $1.2M | — | Filing → |